Advertisement

Oral Contraceptives and the Risk of Breast and Cervical Cancer

  • James O. Drife
Conference paper

Abstract

In this Symposium, we have already heard about epidemiological studies on oral contraception and breast cancer, and about biological studies on steroids and mammary carcinogenesis. I shall try to draw together the biological and epidemiological data on breast and cervical cancer. But today’s workshop concentrates on issues of relevance to the practicing clinician, and I want to begin by putting our discussions into a broader perspective.

Keywords

Breast Cancer Cervical Cancer Endometrial Cancer Oral Contraceptive Cervical Intraepithelial Neoplasia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Smith A (1990) The population bomb has already exploded. Brit Med J 301:681–682.PubMedCrossRefGoogle Scholar
  2. 2.
    Segal SJ, LaGuardia KD (1990) Termination of pregnancy-A global view. Bailliere’s Clin Obstet Gynaecol 4:235–247.CrossRefGoogle Scholar
  3. 3.
    Botting B (1991) Trends in abortion. Population Trends 64:19–29.PubMedGoogle Scholar
  4. 4.
    Loudon I (1990) Obstetrics and the general practitioner. Brit Med J 301:703–707PubMedCrossRefGoogle Scholar
  5. 5.
    Lettenmaier C, Liskin L, Church CA, Harris JA (1988) Mothers’ lives matter: maternal health in the community. Population Reports, Series L, No 7.Google Scholar
  6. 6.
    Potts DM, Crane SF (1993) Contraceptive delivery in the developing world. Brit Med Bull 49:27–39.PubMedGoogle Scholar
  7. 7.
    Drife J (1993) Contraceptive problems in developed countries. Brit Med Bull 49:17–26.PubMedGoogle Scholar
  8. 8.
    Grubb GS (1987) Women’s perceptions of the safety of the pill: A survey in eight developing countries. J Biosoc Sci 19:313–321.CrossRefGoogle Scholar
  9. 9.
    Drife JO (1989) The benefits of combined oral contraceptives. Br J Obstet Gynaecol 96:1225–1228.Google Scholar
  10. 10.
    Henderson IC (1993) Risk factors for breast cancer development.Cancer 71:2127–2140.Google Scholar
  11. 11.
    Drife JO (1993) The benefits and risks of oral contraceptives. New York: Parthenon Publishing.Google Scholar
  12. 12.
    Ross RK, Pike MC, Vessey MP, et al. (1986) Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Brit Med J 293:359–362.CrossRefGoogle Scholar
  13. 13.
    Thorogood M, Vessey MP (1990) Trends in use of oral contraceptives in Britain. Brit J Fam Plan 16:41–53.Google Scholar
  14. 14.
    Gerstman BB, Gross TP, Kennedy DL, et al. (1991) Trends in the content and use of oral contraceptives in the United States, 1964–88. Amer J Pub Hlth 81:90–96.CrossRefGoogle Scholar
  15. 15.
    Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development (1987) Combination oral contraceptive use and the risk of endometrial cancer. J Amer Med Assoc 257:796–800.CrossRefGoogle Scholar
  16. 16.
    Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development (1987) The reduction in risk of ovarian cancer associated with oral-contraceptive use. N Engl J Med 316:650–655.CrossRefGoogle Scholar
  17. 17.
    Drife J (1986) Breast development in puberty. Ann NY Acad Sci 464:58–65.PubMedCrossRefGoogle Scholar
  18. 18.
    Morris D (1977) The naked ape. St Albans: Mayflower.Google Scholar
  19. 19.
    Petrek JA, Hudgins LC, Levine B, et al. (1994) Breast cancer risk and fatty acids in the breast and abdominal tissues. J Natl Cancer Inst 86: 53–56.PubMedCrossRefGoogle Scholar
  20. 20.
    Drife JO (1992) Are breasts redundant organs? Brit Med J 304:1060.CrossRefGoogle Scholar
  21. 21.
    Houlihan MJ, Goldwyn RM (1991) Role of prophylactic mastectomy. In (ed) Stoll BA: Approaches to breast cancer prevention. Norwell: Kluwer, pp 135–148.CrossRefGoogle Scholar
  22. 22.
    Drife JO (1992) Breasts and the media. Brit Med J 304:1514.CrossRefGoogle Scholar
  23. 23.
    Milligan D, Drife JO, Short RV (1975) Changes in breast volume during normal menstrual cycle and after oral contraceptives. Brit Med J iv:494–496.Google Scholar
  24. 24.
    Anderson TJ, Ferguson DJP, Raab GM (1982) Cell turnover in the “resting” human breast: influence of contraceptive pill, age and laterality. Brit J Cancer 46:376–82.PubMedCrossRefGoogle Scholar
  25. 25.
    Masters JRW, Scarisbrick JJ, Drife JO (1977) Cyclic variation of DNA synthesis in human breast epithelium. J Natl Cancer Inst 58:1263–1265.PubMedGoogle Scholar
  26. 26.
    Anderson TJ, Battersby S, King RJB, et al. (1989) Oral contraceptive use influences resting breast proliferation. Hum Pathol 20:1139–1144.PubMedCrossRefGoogle Scholar
  27. 27.
    Schlesselman JJ (1990) Oral contraceptives and breast cancer. Amer J Obstet Gynecol 163:1279–1287.Google Scholar
  28. 28.
    Beral V, Reeves G (1993) Childbearing, oral contraceptive use, and breast cancer. Lancet 341:1102.PubMedCrossRefGoogle Scholar
  29. 29.
    Wingo PA, Lee NC, Ory HW, et al. (1993) Age-specific differences in the relationship between oral contraceptive use and breast cancer. Cancer 71:1506–1517.PubMedCrossRefGoogle Scholar
  30. 30.
    Drife J (1981) The effects of parity and the menstrual cycle on the normal mammary gland and their possible relationship to malignant change. MD Thesis, University of Edinburgh.Google Scholar
  31. 31.
    McPherson K, Drife JO (1986) The pill and breast cancer: why the uncertainty? Brit Med J 293:709–710.CrossRefGoogle Scholar
  32. 32.
    Drife J (1989) The contraceptive pill and breast cancer in young women. Brit Med J 298:1269–1270.PubMedCrossRefGoogle Scholar
  33. 33.
    McPherson K (1993) Childbearing, oral contraceptive use and breast cancer. Lancet 341:1604–1605.PubMedCrossRefGoogle Scholar
  34. 34.
    Herbst AL, Berek JS (1993) Impact of contraception on gynecologic cancers. Amer J Obstet Gynecol 168:1980–1985.Google Scholar
  35. 35.
    Thomas DB (1993) Oral contraceptives and breast cancer. J Natl Cancer Inst 85:359–364.PubMedCrossRefGoogle Scholar
  36. 36.
    Delgado-Rodriguez M, Sillero-Arenas M, Martin-Moreno JM, Galvez-Vargas R (1992) Oral contraceptives and cancer of the cervix uteri. Acta Obstet Gynecol Scand 71:368–376.PubMedCrossRefGoogle Scholar
  37. 37.
    Gram IT, Macaluso M, Stalsberg H (1992) Oral contraceptive use and the incidence of cervical intraepithelial neoplasia. Amer J Obstet Gynecol 167:40–44.Google Scholar
  38. 38.
    Turnquest MA (1993) Oral contraceptive use and incidence of cervical intraepithelial neoplasia. Amer J Obstet Gynecol 168:1895.Google Scholar
  39. 39.
    Thiry L, Vokaer R, Detremmerie O, Bollen A, Hallez S (1992) Contraception, papillomavirus, and cervical cancer. Lancet 339:616.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1996

Authors and Affiliations

  • James O. Drife

There are no affiliations available

Personalised recommendations